Photo: SHVETS production on Pexels
By the Leanova Research Team
If you have PCOS (often called PCOD in India) and you are hoping to have a baby in the next year or two, you have probably heard two things at once. Losing some weight can make periods more regular and help ovulation. And weight-loss injections such as Mounjaro (tirzepatide) and Wegovy or Ozempic (semaglutide) are now widely talked about for PCOS.
What gets lost is the practical part: these medicines are not meant to be taken during pregnancy, one of them can make the contraceptive pill less reliable for a while, and each needs a gap between the last dose and trying to conceive. This guide brings the guidance together in one place so you can plan with your doctor.
Why weight matters for fertility in PCOS
PCOS is common in India. A nationwide study published in JAMA Network Open in 2024 found a weighted prevalence of 19.6% among women aged 18 to 40 using the Rotterdam criteria, and obesity was present in 43.2% of the women with PCOS in that study [1].
The 2023 International Evidence-based Guideline for PCOS, the main global guideline, says women with PCOS should be counselled on the adverse impact of excess weight on clinical pregnancy, miscarriage and live birth rates after fertility treatment [2]. It also notes that a healthy lifestyle has benefits even without weight loss, and that in women with higher weight, weight management can bring significant clinical improvements [2].
Two points are easy to miss:
- Pregnancy is often possible with PCOS. The guideline asks doctors to reassure women that pregnancy can often be achieved, naturally or with help [2].
- Weight loss is a support, not the fertility treatment itself. When ovulation does not happen on its own, the guideline recommends letrozole as the first-line medicine for ovulation induction in women with PCOS who have no other fertility factors [2]. Your gynaecologist decides this.
What about weight-loss injections for PCOS?
The 2023 guideline says anti-obesity medicines, including the GLP-1 medicines liraglutide and semaglutide, could be considered alongside active lifestyle change to manage higher weight in adults with PCOS, following the same rules as for the general population [2]. In the same section it adds three cautions [2]:
- Doctors should make sure effective contraception is in place when pregnancy is possible, because pregnancy safety data are lacking.
- Doses should be increased gradually to reduce stomach side effects.
- Decisions should weigh side effects, the possible need for long-term use, and the high risk of weight regain after stopping.
Just as important is what the guideline does not recommend. For fertility outcomes specifically, it says anti-obesity medicines in PCOS should be used only in research settings until their effectiveness and safety are established [2]. In plain terms, these injections are used to treat weight. They are not a fertility treatment, and none of them is approved specifically for PCOS.
Mounjaro and the contraceptive pill
This is the point that surprises most women.
Mounjaro slows how quickly the stomach empties, and this effect is largest after the first dose and becomes smaller over time. Its official prescribing information states that it may reduce how well oral hormonal contraceptives work [3]. The advice is to switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase [3]. Contraceptives that are not taken by mouth, such as an intrauterine device (coil) or an implant, are not expected to be affected [3].
The UK medicines regulator (MHRA) issued a reminder in June 2025 for the same reason: women on these medicines must use effective contraception, and women on Mounjaro who are overweight should not rely on the pill alone [4][5].
For semaglutide (Wegovy, Ozempic and Rybelsus), the UK Faculty of Sexual and Reproductive Healthcare says there is currently no evidence that it reduces the effectiveness of the pill [6]. Effective contraception is still needed while on treatment [5].
Many women with PCOS are already on the combined pill to regulate their periods, so this matters. If you are on the pill and starting or stepping up Mounjaro, ask your doctor which back-up method suits you.
How long to stop before trying to get pregnant
These medicines stay in the body for a while after the last injection, so the medicines information recommends a wash-out period, with contraception continued during it [5][7]:
| Medicine | Stop at least this long before trying to conceive |
|---|---|
| Semaglutide (Wegovy, Ozempic, Rybelsus) | 2 months |
| Tirzepatide (Mounjaro) | 1 month |
| Liraglutide | Can be stopped just before trying, because it leaves the body quickly |
The MHRA also says these medicines should not be used while trying to get pregnant, during pregnancy, or while breastfeeding [4].
What if I got pregnant while on the injection?
Unplanned pregnancies do happen, sometimes because weight loss brings back ovulation, or because the pill was less reliable early in treatment. If this happens:
- Contact your doctor promptly and stop the medicine as advised. The MHRA advises stopping as soon as possible and speaking to a healthcare professional [4].
- Try not to panic. The best human data so far are reassuring but limited. A large multinational study of more than 50,000 pregnancies in women with type 2 diabetes found no increased risk of major birth defects with GLP-1 medicines taken around conception and in early pregnancy compared with insulin (adjusted relative risk 0.95, 95% CI 0.72 to 1.26) [8]. The authors noted that some estimates were imprecise and that confirmation is needed [8].
Because the evidence is still thin, the safest plan is to time pregnancy deliberately rather than rely on this reassurance.
A sensible plan for the year before pregnancy
Every woman is different, but a doctor-led plan usually covers:
- A preconception check. The PCOS guideline recommends reviewing weight, blood pressure, smoking, alcohol, diet, sleep, mental health and folic acid, with a higher folic acid dose if your BMI is above 30 [2]. It also recommends a glucose tolerance test (OGTT) and a blood pressure check when planning pregnancy, because women with PCOS have a higher risk of diabetes and high BP in pregnancy [2].
- A realistic weight goal. For many women, the aim is steady loss and building habits that last, using Indian meals you can keep up: more vegetables, lentils, eggs, curd, cottage cheese, fish or chicken, and fewer refined carbs and sugary drinks.
- A clear decision about medicines. If a weight-loss injection is appropriate for you, agree on a start date, a contraception plan, and a stop date that leaves the full wash-out period before you start trying.
- Planning for after stopping. Weight can creep back after stopping these medicines [2]. A protein-rich diet, strength training and regular follow-up help you keep as much of the benefit as possible going into pregnancy.
- A fertility review if needed. If periods remain irregular or you have been trying without success, see a gynaecologist about ovulation treatment such as letrozole rather than waiting.
When to see a doctor
See a registered physician or gynaecologist if:
- your periods are absent for months, or come less often than every 35 days
- you have been trying to conceive for 12 months (or 6 months if you are over 35)
- you are on a weight-loss injection and your period is late, or a pregnancy test is positive
- you are considering buying a weight-loss injection without a prescription; please don't, especially if pregnancy is possible
PCOS, weight and the years after 40
Planning a pregnancy is only one stage. Women with PCOS carry a higher long-term risk of diabetes and heart disease, and many notice weight gain around the waist in their 40s as they approach menopause. The habits you build now, and regular checks of HbA1c, lipids and blood pressure, keep paying off long after your fertility years.
Frequently asked questions
Can I take Mounjaro or Wegovy while trying to get pregnant?
No. The MHRA advises that these medicines should not be used while trying to get pregnant, during pregnancy or while breastfeeding [4]. Stop semaglutide at least 2 months and tirzepatide at least 1 month before trying, and use contraception during that gap [5][7].
Does Mounjaro stop the pill from working?
It can make oral contraceptives less reliable for a while, mainly after the first dose and after dose increases. The prescribing information advises switching to a non-oral method or adding condoms for 4 weeks after starting and after each dose increase [3].
Do weight-loss injections improve fertility in PCOS?
They can help with weight, which is linked to better pregnancy outcomes. However, the 2023 international PCOS guideline recommends using these medicines for fertility outcomes only in research settings until more evidence is available [2]. They are not a fertility treatment.
How much weight do I need to lose with PCOS to get pregnant?
There is no single number. The guideline focuses on preventing further weight gain and on steady, sustainable weight management, and notes that a healthy lifestyle helps even without weight loss [2]. Your doctor will set a goal based on your health and your timeline.
I got pregnant on Ozempic. Will my baby be harmed?
Contact your doctor promptly. The largest study so far, in women with type 2 diabetes, did not find a higher rate of major birth defects with early-pregnancy GLP-1 exposure than with insulin, but the data are limited [8]. Your doctor will guide you on stopping the medicine and on your antenatal care.
Is metformin safer than injections if I want a baby soon?
Metformin is widely used in PCOS, and the guideline discusses its use around pregnancy in specific situations [2]. Whether it suits you depends on your blood sugar, your weight and your fertility plan, so decide this with your doctor.
Talk to Leanova
Leanova is led by registered physicians who look at the whole picture: hormones, blood sugar, liver, heart risk and weight. Whether you are in Hyderabad, Delhi, Chandigarh, Bengaluru, Maharashtra or anywhere else in India, we can help you build a safe, timed plan for weight loss before pregnancy, including whether medicines make sense for you and when to stop them.
- WhatsApp: +91 93633 43330
- Email: care@leanova.in
- Website: leanova.in
References
- Ganie MA, Chowdhury S, Suri V, et al. Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women. JAMA Netw Open. 2024;7(10):e2440583. https://pmc.ncbi.nlm.nih.gov/articles/PMC11581580/
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. 2023. (Recommendations 3.1.5, 3.1.6, 4.5.1 to 4.5.4, 5.1.1, 5.1.2, 5.3.1, 5.9.1, 4.10.6, 4.10.7.) https://pmc.ncbi.nlm.nih.gov/articles/PMC10477934/
- Eli Lilly and Company. Mounjaro (tirzepatide) US Prescribing Information, sections 7.2 and 8.3. https://pi.lilly.com/us/mounjaro-uspi.pdf
- Medicines and Healthcare products Regulatory Agency (MHRA). Women on "skinny jabs" must use effective contraception, MHRA urges in latest guidance. GOV.UK, June 2025. https://www.gov.uk/government/news/women-on-skinny-jabs-must-use-effective-contraception-mhra-urges-in-latest-guidance
- MHRA. GLP-1 medicines for weight loss and diabetes: what you need to know. GOV.UK. https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know
- Faculty of Sexual and Reproductive Healthcare (FSRH). GLP-1 agonists and contraception: patient information leaflet. https://www.cosrh.org/Common/Uploaded%20files/documents/Patient-information-GLP-1-agonists-and-contraception.pdf
- National Institute for Health and Care Excellence (NICE). Overweight and obesity management (NG246): a practical guide to using medicines, shared decision making. https://www.nice.org.uk/guidance/ng246/resources/a-practical-guide-to-using-medicines-to-manage-overweight-and-obesity-15299628589/chapter/Shared-decision-making
- Cesta CE, Rotem R, Bateman BT, et al. Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. JAMA Intern Med. 2024;184(2):144-152. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2812743
Disclaimer: This article is for general education only and is not a substitute for personal medical advice, diagnosis or treatment. GLP-1 and GIP/GLP-1 medicines are not approved for treating PCOS or infertility and should not be used during pregnancy, while trying to conceive or while breastfeeding. All medicines, including weight-loss injections, metformin, contraceptives and fertility medicines, should be started, changed or stopped only under the guidance of a registered physician. Side effects can occur, weight regain is common after stopping weight-loss medicines, individual results vary, and no specific outcome is guaranteed.